Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2450-2459
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2450
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2450
Table 2 Number of indications scored as ”inappropriate”, ”uncertain”, ”appropriate”, or as ”disagreement” in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
| First Round Results | Second Round Results | |||||||
| Agreement | Frequency | Percent | CumulativeFrequency | CumulativePercent | Frequency | Percent | CumulativeFrequency | CumulativePercent |
| Inappropriate | 73 | 37.1 | 73 | 37.1 | 94 | 46.5 | 94 | 46.5 |
| Uncertain | 39 | 19.8 | 112 | 56.9 | 44 | 21.8 | 138 | 68.3 |
| Appropriate | 59 | 29.9 | 171 | 86.8 | 62 | 30.7 | 200 | 99.0 |
| Disagreement | 26 | 13.2 | 197 | 100.0 | 2 | 1.0 | 202 | 100.0 |
- Citation: Strosberg JR, Fisher GA, Benson AB, Anthony LB, Arslan B, Gibbs JF, Greeno E, Iyer RV, Kim MK, Maples WJ, Philip PA, Wolin EM, Cherepanov D, Broder MS. Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors. World J Gastroenterol 2015; 21(8): 2450-2459
- URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2450.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2450